Kaleidos Pharma Inc., National Institutes of Health deal

Kaleidos and the NIH's NIAID division of AIDS will conduct a non-human primate study to evaluate the potential of Kaleidos' transforming growth factor alpha (TGF-alpha) to increase CD4 T-cell counts i...